Gentex Misses A Bit (GNTX)
Gentex Corporation (NASDAQ: GNTX) is down after earnings this morning, but things are not looking as bad as they were shortly before the opening bell. The maker of advanced mirrors for cars and other auto…
Gentex Corporation (NASDAQ: GNTX) is down after earnings this morning, but things are not looking as bad as they were shortly before the opening bell. The maker of advanced mirrors for cars and other auto…
Broadridge Financial Solutions (NYSE: BR) has a report out for investors who like to invest internationally and in emerging markets. It highlights just how difficult it can be for the investors inside the United States…
Not all public companies are belt and suspenders outfits. Some are also very unique models with little to no competition. Rick’s Cabaret International, Inc. (NASDAQ: RICK) is the largest gentlemen’s club owner and it…
coutesy of Exxon Mobile Corp.Exxon Mobil Corporation (NYSE: XOM) is out with earnings. Big Oil’s fourth quarter showed net earnings gain of about 2% to $9.4 billion, or $1.97 EPS. Thomson Reuters had estimates…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) Reiterated Buy and Raised target to $80 at…
Radioshack Corporation (NYSE: RSH) was already doing poorly after its preannounced earnings report on Monday evening. The reaction had shares down 19.75% at $8.21 last night with more than 1.5 million shares traded in the…
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) is out with news that the preliminary results of the pain score portion of the expansion phase of Ampion in Knee trial which was recently completed in Australia. This company…
BP plc (NYSE: BP) is not feeling any continued pain this morning after Monday’s news of an underwater well leak being reported. The oil giant shut part of its North Sea field after the…
Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s guidance may be getting in the way a bit. The drug giant turned in…
Well-known and often a bit rash, Jim Rogers is out bashing many things tonight and he made a brief remote appearance with Larry Kudlow on CNBC on Monday evening. Among them, he said he…
Rex Energy Corporation (NASDAQ: REXX) managed to sting its holders in the after-hours session after announcing a 7 million share secondary offering. The company is selling all of the shares in this offering and…
Baidu, Inc. (NASDAQ: BIDU) has seen quite a bit of stock options trading today, and it was a day in which stock trading was more active than normal as well. We do not have…
RadioShack Corporation (NYSE: RSH) pre-announced results for its fourth quarter and the figures are just awful. This is where a value stock becomes a value trap. Sales rose about 6% to $1.39 billion, up…
Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial as a stock can get in biotech. Now we have reason yet again to question whether or not this small biotech outfit can survive. The…
Hasbro, Inc. (NASDAQ-HAS) has partnered with Relativity Media to develop and produce a new movie based upon the Stretch Armstrong character. The action hero figure dates back to the 1970s. If all goes well,…
National Bank of Greece S.A. (NYSE: NBG) is actually holding up rather well considering the woes of an ultimate Greek government debt default risk and that is whether or not a deal gets signed…
You will probably get to see this and hear about in the news more and more in the coming weeks. Forget about an electric car. What about a solar car? A new solar-powered car…
The problems for Carnival Corporation (NYSE: CCL) keep mounting after its Costa lines deadly accident earlier this month. The company has outlined up to a $175 million charge. The move is not just direct…
Pershing Square Capital Management, L.P. has announced that its Town Hall Meeting intended to give Canadian Pacific Railway Limited (NYSE: CP) shareholders the opportunity to meet Pershing Square’s slate of nominees. The activist investor’s…
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is up 17.8% at $14.29 on word that the FDA finally gave its once-a-week diabetes drug Bydureon approval. Alkermes Inc. (NASDAQ: ALKS) is higher as it gets a royalty. …